FALBERG KATHRYN E received a stock award from AIMMUNE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/29/2020ACC: 0000899243-20-014615
Director
Since May 2019
+23.24K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
23.24K acquired
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
+7.84K
Price / share
—
Trade value
—
% of position
12.0%
5/27/2020
65.19K→73.03K
Total
Net shares
+7.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 5/27/2020 | A · Award | +7.84K | — | — | 12.0% | 65.19K | 73.03K |
| Total | +7.84K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15.40K shares
Shares
+15.40K
Strike price
17.11
Held after
15.40K
Exercisable
—
5/27/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15.40K shares | 5/27/2020 | A · Award | +15.40K | 17.11 | — | 15.40K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock, $0.0001 par value
IndirectShares owned69.89K
Total
69.89K indirect69.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.0001 par value | 69.89K | Indirect |
| Total | 69.89K | 69.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported